NDC 0641-6173-01 - Dicyclomine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6173
- Requested NDC
- 0641-6173-01
- Package NDCs from labels
- 0641-6173-01, 0641-6173-10
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Effective date
- 2024-04-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dicyclomine Hydrochloride - Hikma Pharmaceuticals USA Inc. | Hikma Pharmaceuticals USA Inc. | 2024-04-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6173-01 | Dicyclomine Hydrochloride | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 2 | 6 | |
| 0641-6173-10 | Dicyclomine Hydrochloride | 10 in 1 CARTON | INJECTION | 10 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6173-01 | ML - Milliliter | 0641-6173 | ab15b7e1-d21f-4c4b-8c68-2f96570bca38 | 1 | 2016-04-04 |
| 0641-6173-10 | ML - Milliliter | 0641-6173 | 165bccf2-7ebb-4747-b9ae-cc32f2a1916a | 1 | 2016-04-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dicyclomine hydrochloride | DICYCLOMINE HYDROCHLORIDE | Rising Pharma Holdings, Inc. | 0a97e9c8-7046-4b92-93ad-dd9e01ce0fc4 | 2026-01-27 | Warnings, Adverse reactions | CQ903KQA31 |
| DICYCLOMINE HYDROCHLORIDE | DICYCLOMINE HYDROCHLORIDE | Rising Pharma Holdings, Inc. | 029baf6d-4e85-48fd-9efc-158fe0f629bb | 2026-01-20 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 3ee013cc-ab23-40a1-a44d-1d027c63b132 | 2026-01-19 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | A-S Medication Solutions | 59422db6-b22d-447a-9393-46347406b338 | 2026-01-19 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | A-S Medication Solutions | 4f6f4402-865b-44fb-9bfe-4e224d57e6dc | 2026-01-19 | Warnings, Adverse reactions | CQ903KQA31 |
| DICYCLOMINE HYDROCHLORIDE | DICYCLOMINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | dd3a8428-f71f-4f39-91c9-328d2a30eeba | 2026-01-08 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | Northwind Health Company, LLC | da82cb46-7b4b-1ef5-e053-2a95a90ad10d | 2026-01-01 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | Northwind Health Company, LLC | d9bb7ff1-8dbc-d191-e053-2995a90a13db | 2026-01-01 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | Northwind Health Company, LLC | c195b8ea-c1bf-453f-e053-2a95a90a2121 | 2026-01-01 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine hydrochloride | DICYCLOMINE HYDROCHLORIDE | Northwind Health Company, LLC | 1d9acff5-6e8c-58dd-e063-6394a90a38f2 | 2026-01-01 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | A-S Medication Solutions | 1aebc66d-0636-45ef-8110-7ff49d4dced5 | 2025-12-31 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine hydrochloride | DICYCLOMINE HYDROCHLORIDE | Redpharm Drug | 3b0ae3ed-77ef-d0df-e063-6294a90a7d17 | 2025-12-25 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | Redpharm Drug | 3252540c-980d-40ca-e063-6394a90ad1c9 | 2025-12-18 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine hydrochloride | DICYCLOMINE HYDROCHLORIDE | Redpharm Drug | 3745661f-5d24-487d-e063-6294a90a5a68 | 2025-12-13 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | QPharma, Inc. | f5dd6ecc-440d-6c47-e053-2a95a90a92d3 | 2025-12-03 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine hydrochloride | DICYCLOMINE HYDROCHLORIDE | Redpharm Drug | 3de47f8d-e265-3f40-e063-6394a90aa3b0 | 2025-12-02 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine hydrochloride | DICYCLOMINE HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 43e30378-6376-caab-e063-6294a90a8696 | 2025-11-18 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine hydrochloride | DICYCLOMINE HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 3c6dec02-b146-dd36-e063-6294a90ad7d2 | 2025-11-03 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine hydrochloride | DICYCLOMINE HYDROCHLORIDE | A-S Medication Solutions | 3713ae82-f36d-4491-9978-3111599ceafb | 2025-11-01 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine hydrochloride | DICYCLOMINE HYDROCHLORIDE | A-S Medication Solutions | acb5ab87-2eb4-4fc9-b7f1-cc8cb71bd73b | 2025-10-29 | Warnings, Adverse reactions | CQ903KQA31 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.